Table 1.
Baseline characteristics and outcome of 1158 treated patients.
Table 2.
Laboratory baseline and follow up parameters (n = 1158 for hemoglobin at admission, n = 939 for hemoglobin at 24h and n = 960 for hemoglobin nadir until day 5).
Table 3.
Predictors of outcome and survival in multivariable regression analysis and of infarct volumes and infarct growth in linear regression analysis.
For each laboratory parameter, a separate analysis was performed and the results shown for other non-laboratory parameters are based on the model with inclusion of the first listed laboratory parameter. Hemoglobin at admission was available for 1158 patients, hemoglobin at 24h for 939 patients, and hemoglobin nadir until day 5 for 960 patients.
Fig 1.
Distribution of 3 months outcome (as measured by modified Rankin Scale score) in dependence on anemia at hospital admission (a) and newly observed anemia until day 5 (b).
Fig 2.
Influence of baseline anemia and newly observed anemia on mean infarct sizes and infarct growth.
Table 4.
Association between newly observed anemia and extent of infarction in 180 patients treated with EVT.